Proparacaine and Mydriatic Eye Drops

• Status: Terminated
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital of Philadelphia
• Treatments: Mydriatics; Ophthalmic Solutions; Pharmaceutical Solutions; Propoxycaine; Proxymetacaine; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Infants admitted to the Pennsylvania Hospital NICU who require an ophthalmologic examination.

Exclusion Criteria:

• Infants with congenital anomalies, seizures, or other neurologic conditions or malformations that may alter the pain response

• Infants with corneal abrasions, corneal ulcers or other relative or absolute contraindications to proparacaine administration